T1	Parsing_Error 0 18	Healthy Volunteers
T2	Condition 33 50	contraindications
T3	Drug 20 32	Treprostinil
R1	AND Arg1:T2 Arg2:T3	
T4	Condition 58 74	hypersensitivity
T5	Drug 78 90	treprostinil
R2	AND Arg1:T4 Arg2:T5	
T6	Drug 94 115	any of the excipients
R3	Subsumes Arg1:T5 Arg2:T6	
T7	Condition 117 148	Pulmonary arterial hypertension
T8	Condition 160 182	veno-occlusive disease
R4	AND Arg1:T7 Arg2:T8	
T9	Condition 184 208	Congestive heart failure
T10	Condition 223 251	left ventricular dysfunction
T11	Condition 260 281	hepatic insufficiency
T12	Qualifier 216 222	severe
R5	Has_qualifier Arg1:T10 Arg2:T12	
T13	Qualifier 253 259	Severe
R6	Has_qualifier Arg1:T11 Arg2:T13	
T14	Measurement 283 293	Child-Pugh
T15	Value 294 301	stage C
R7	Has_value Arg1:T14 Arg2:T15	
R8	Subsumes Arg1:T13 Arg2:T14	
*	OR T10 T11
T16	Condition 313 335	gastrointestinal ulcer
T17	Qualifier 304 312	Evolving
R9	Has_qualifier Arg1:T16 Arg2:T17	
T18	Condition 337 360	intracranial hemorrhage
T19	Condition 369 375	trauma
T20	Temporal 362 368	recent
R10	Has_temporal Arg1:T19 Arg2:T20	
T21	Condition 385 429	clinical condition that may lead to bleeding
T22	Undefined_semantics 385 429	clinical condition that may lead to bleeding
T23	Condition 431 441;454 476	Congenital valvular abnormalities
T24	Condition 445 476	acquired valvular abnormalities
T25	Qualifier 477 503	with cardiac repercussions
R11	Has_qualifier Arg1:T23 Arg2:T25	
R12	Has_qualifier Arg1:T24 Arg2:T25	
T26	Condition 512 534	ischemic heart disease
T27	Qualifier 505 511	Severe
T28	Condition 538 553	unstable angina
R13	Has_qualifier Arg1:T26 Arg2:T27	
*	OR T28 T26 T24 T23 T21 T29 T31 T35
T29	Condition 555 576	Myocardial infarction
T30	Temporal 577 599	in the last six months
R14	Has_temporal Arg1:T29 Arg2:T30	
T31	Condition 601 636	Decompensated cardiac insufficiency
T32	Qualifier 637 661	not medically controlled
R15	Has_qualifier Arg1:T31 Arg2:T32	
T33	Condition 670 681	arrhythmias
T34	Qualifier 663 669	Severe
R16	Has_qualifier Arg1:T33 Arg2:T34	
R17	AND Arg1:T31 Arg2:T33	
T35	Condition 683 706	Cerebrovascular lesions
T36	Condition 716 741	transient ischemic attack
T37	Condition 743 749	stroke
*	OR T37 T36
T38	Scope 716 749	transient ischemic attack, stroke
R18	Subsumes Arg1:T35 Arg2:T38	
T39	Temporal 765 793	within the last three months
R19	Has_temporal Arg1:T35 Arg2:T39	
T40	Context_Error 796 879	Persons referred to in Articles L1121-5 to L1121-8 of the French Public health Code
T41	Condition 881 889	pregnant
T42	Person 890 895	woman
A1	Optional T42
R20	AND Arg1:T42 Arg2:T41	
T43	Condition 897 907	parturient
T44	Condition 909 916	nursing
T45	Observation 932 951	deprived of liberty
*	OR T45 T44 T43 T41
T46	Scope 881 951	pregnant woman, parturient, nursing mother, person deprived of liberty
R21	Subsumes Arg1:T40 Arg2:T46	
T47	Context_Error 1079 1129	Subject in an exclusion period from another study,
T48	Non-query-able 1079 1129	Subject in an exclusion period from another study,
T49	Non-query-able 1131 1285	Subject who would receive more than 4500 euros of compensation due to his participation in other biomedical research in the 12 months preceding this study
T50	Context_Error 1131 1285	Subject who would receive more than 4500 euros of compensation due to his participation in other biomedical research in the 12 months preceding this study
T51	Condition 1287 1305	Systemic sclerosis
T52	Drug 1317 1325	Iloprost
T53	Temporal 1343 1364	in the previous month
T54	Temporal 1376 1398	in the following month
T55	Observation 1368 1375	planned
R22	Has_temporal Arg1:T52 Arg2:T53	
T56	Drug 1317 1325	Iloprost
R23	Has_mood Arg1:T56 Arg2:T55	
R24	Has_temporal Arg1:T56 Arg2:T54	
*	OR T56 T52
T57	Non-query-able 1368 1398	planned in the following month
T58	Drug 1435 1443	bosentan
T59	Drug 1445 1455	sildenafil
T60	Drug 1459 1483	calcium channel blockers
T61	Temporal 1484 1505	in the previous month
T62	Temporal 1509 1531	in the following month
*	OR T62 T61
T63	Scope 1484 1531	in the previous month or in the following month
T64	Scope 1435 1483	bosentan, sildenafil or calcium channel blockers
R25	Has_scope Arg1:T64 Arg2:T63	
T65	Procedure 1533 1554	Digital Sympathectomy
T66	Procedure 1558 1583	botulinum toxin injection
T67	Observation 1584 1591	planned
T68	Non-query-able 1584 1591	planned
T69	Temporal 1592 1614	in the following month
*	OR T66 T65
T70	Scope 1533 1583	Digital Sympathectomy or botulinum toxin injection
R26	Has_mood Arg1:T70 Arg2:T67	
R27	Has_temporal Arg1:T70 Arg2:T69	
T71	Condition 1642 1656	digital ulcers
T72	Observation 1628 1641	superinfected
R28	Has_context Arg1:T71 Arg2:T72	
T73	Drug 1658 1670	Treprostinil
T74	Condition 1671 1688	contraindications
R29	AND Arg1:T74 Arg2:T73	
T75	Condition 1696 1712	hypersensitivity
T76	Drug 1716 1728	treprostinil
T77	Drug 1732 1753	any of the excipients
*	OR T77 T76
T78	Scope 1716 1753	treprostinil or any of the excipients
R30	Has_scope Arg1:T75 Arg2:T78	
T79	Condition 1755 1786	Pulmonary arterial hypertension
T80	Condition 1798 1820	veno-occlusive disease
R31	AND Arg1:T79 Arg2:T80	
T81	Condition 1822 1846	Congestive heart failure
T82	Condition 1861 1889	left ventricular dysfunction
T83	Qualifier 1854 1860	severe
R32	Has_qualifier Arg1:T82 Arg2:T83	
T84	Condition 1898 1919	hepatic insufficiency
T85	Qualifier 1891 1897	Severe
T86	Measurement 1921 1931	Child-Pugh
T87	Value 1932 1939	stage C
R33	Has_value Arg1:T86 Arg2:T87	
R34	Subsumes Arg1:T85 Arg2:T86	
R35	Has_qualifier Arg1:T84 Arg2:T85	
T88	Condition 1951 1973	gastrointestinal ulcer
T89	Condition 1975 1998	intracranial hemorrhage
T90	Condition 2007 2013	trauma
T91	Temporal 2000 2006	recent
R36	Has_temporal Arg1:T90 Arg2:T91	
T92	Condition 2023 2067	clinical condition that may lead to bleeding
T93	Undefined_semantics 2023 2067	clinical condition that may lead to bleeding
T94	Condition 2069 2079;2092 2114	Congenital valvular abnormalities
T95	Condition 2083 2114	acquired valvular abnormalities
T96	Qualifier 2115 2141	with cardiac repercussions
R37	Has_qualifier Arg1:T94 Arg2:T96	
R38	Has_qualifier Arg1:T95 Arg2:T96	
T97	Condition 2150 2172	ischemic heart disease
T98	Qualifier 2143 2149	Severe
R39	Has_qualifier Arg1:T97 Arg2:T98	
T99	Condition 2176 2191	unstable angina
T100	Condition 2193 2214	Myocardial infarction
T101	Temporal 2215 2237	in the last six months
R40	Has_temporal Arg1:T100 Arg2:T101	
T102	Condition 2239 2274	Decompensated cardiac insufficiency
T103	Condition 2308 2319	arrhythmias
T104	Qualifier 2301 2307	Severe
R41	Has_qualifier Arg1:T103 Arg2:T104	
T105	Condition 2321 2344	Cerebrovascular lesions
T106	Condition 2354 2379	transient ischemic attack
T107	Condition 2381 2387	stroke
T108	Temporal 2403 2431	within the last three months
*	OR T107 T106
T109	Scope 2354 2387	transient ischemic attack, stroke
R42	Subsumes Arg1:T105 Arg2:T109	
R43	Has_temporal Arg1:T105 Arg2:T108	
*	OR T88 T79 T81 T82 T84 T89
T110	Scope 2000 2013	recent trauma
R44	Has_scope Arg1:T89 Arg2:T110	
R45	Subsumes Arg1:T110 Arg2:T92	
*	OR T97 T99 T92 T94 T95 T100 T102 T103 T105
T111	Context_Error 2434 2517	Persons referred to in Articles L1121-5 to L1121-8 of the French Public health Code
T112	Condition 2519 2527	pregnant
T113	Person 2528 2533	woman
A2	Optional T113
R46	AND Arg1:T113 Arg2:T112	
T114	Condition 2535 2545	parturient
T115	Condition 2547 2554	nursing
T116	Observation 2570 2589	deprived of liberty
T117	Observation 2637 2666	subject to a legal protection
*	OR T115 T114 T113 T116 T117
T118	Scope 2519 2666	pregnant woman, parturient, nursing mother, person deprived of liberty by judicial or administrative decision, person subject to a legal protection
R47	Subsumes Arg1:T111 Arg2:T118	
T119	Non-query-able 2717 2766	Subject in an exclusion period from another study
T120	Context_Error 2717 2766	Subject in an exclusion period from another study
T121	Non-query-able 2769 2923	Subject who would receive more than 4500 euros of compensation due to his participation in other biomedical research in the 12 months preceding this study
